BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Y, Wu YF, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Wang T, Liu FQ. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World J Gastrointest Oncol 2019; 11(4): 310-321 [PMID: 31040896 DOI: 10.4251/wjgo.v11.i4.310]
URL: https://www.wjgnet.com/1948-5182/full/v11/i4/310.htm
Number Citing Articles
1
Quan Chen, Yu Zhang, Zhen‐Dong Yue, Hong‐Wei Zhao, Lei Wang, Zhen‐Hua Fan, Fu‐Quan Liu. High‐mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shuntJournal of Hepato-Biliary-Pancreatic Sciences 2020; 27(8): 522 doi: 10.1002/jhbp.770
2
Xiang Zhou, Bin-Bin Cai, Xiang-Qing Hou, Xing-Kai Kang, Xiang-Xiang Xu, Wei-Ming Wang. Development and validation of a risk score for predicting mortality after resection of primary hepatocellular carcinomaAging 2020; 12(12): 11878 doi: 10.18632/aging.103360
3
Zheng Song, Xiujuan Chang, Yongping Yang. Management of upper gastrointestinal bleeding in advanced hepatocellular carcinoma with portal hypertension and variceal bleeding during receiving tyrosine kinase inhibitors therapy: Beyond and known frontiersLiver Cancer International 2023; 4(3-4): 127 doi: 10.1002/lci2.78
4
Yan Chen, Xuemei Ma, Xuefeng Zhang, Jing Luo, Linjing An, Yu Zhang, Xiujuan Chang, Zheng Dong, Wei Zhang, Huifang Kong, Jun Zhao, Huiguo Ding, Fuquan Liu, Yongping Yang. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blockerHepatology International 2022; 16(6): 1379 doi: 10.1007/s12072-022-10388-7